SCYNEXIS, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross
SCYNEXIS, Inc. (SCYX) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross of 35.00 thousand shares for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Shareholders' Equity › Shares Granted or Issued, Share-Based Payment Arrangement
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross · last filed 2026-08-10
- SCYNEXIS, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2025-12-31 was 0.00 shares.
- SCYNEXIS, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2025-09-30 was 0.00 shares, a 100.00% decline year-over-year.
- SCYNEXIS, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2025-06-30 was 138.00K shares, a 0.00% change year-over-year.
- SCYNEXIS, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2025-03-31 was 671.92K shares, a 22.06% decline year-over-year.
- SCYNEXIS, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2025 was 809.92K shares, a 24.31% decline from fiscal 2024.
- SCYNEXIS, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2024 was 1.07M shares, a 253.16% increase from fiscal 2023.
- SCYNEXIS, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2023 was 303.00K shares, a 63.67% decline from fiscal 2022.
- SCYNEXIS, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2022 was 834.00K shares, a 4.58% decline from fiscal 2021.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 12 month |
|---|---|---|---|---|
| 2026-06-30 | 35.00K shares 10-Q · filed 2026-08-10 | |||
| 2025-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-04 | 0.00 shares derived: sum of 2 quarters · filed 2026-03-04 | 138.00K shares derived: sum of 3 quarters · filed 2026-03-04 | 809.92K shares 10-K · filed 2026-03-04 |
| 2025-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | 138.00K shares derived: sum of 2 quarters · filed 2025-11-05 | 809.92K shares 10-Q · filed 2025-11-05 | 809.92K shares derived: sum of 4 quarters · filed 2025-11-05 |
| 2025-06-30 | 138.00K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-13 | 809.92K shares 10-Q · filed 2025-08-13 | 809.92K shares derived: sum of 3 quarters · filed 2025-08-13 | 879.92K shares derived: sum of 4 quarters · filed 2025-08-13 |
| 2025-03-31 | 671.92K shares 10-Q · filed 2025-05-15 | 671.92K shares derived: sum of 2 quarters · filed 2025-05-15 | 741.92K shares derived: sum of 3 quarters · filed 2025-05-15 | 879.92K shares derived: sum of 4 quarters · filed 2025-05-15 |
| 2024-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-12 | 70.00K shares derived: sum of 2 quarters · filed 2025-03-12 | 208.00K shares derived: sum of 3 quarters · filed 2025-03-12 | 1.07M shares 10-K · filed 2025-03-12 |
| 2024-09-30 | 70.00K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-06 | 208.00K shares derived: sum of 2 quarters · filed 2024-11-06 | 1.07M shares 10-Q · filed 2024-11-06 | 1.07M shares derived: sum of 4 quarters · filed 2024-11-06 |
| 2024-06-30 | 138.00K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | 1.00M shares 10-Q · filed 2024-08-08 | 1.00M shares derived: sum of 3 quarters · filed 2024-08-08 | 1.00M shares derived: sum of 4 quarters · filed 2024-08-08 |
| 2024-03-31 | 862.06K shares 10-Q · filed 2024-05-08 | 862.06K shares derived: sum of 2 quarters · filed 2024-05-08 | 862.06K shares derived: sum of 3 quarters · filed 2024-05-08 | 940.06K shares derived: sum of 4 quarters · filed 2024-05-08 |
| 2023-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-28 | 0.00 shares derived: sum of 2 quarters · filed 2024-03-28 | 78.00K shares derived: sum of 3 quarters · filed 2024-03-28 | 303.00K shares 10-K · filed 2024-03-28 |
| 2023-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13 | 78.00K shares derived: sum of 2 quarters · filed 2023-11-13 | 303.00K shares 10-Q · filed 2023-11-13 | 473.00K shares derived: sum of 4 quarters · filed 2023-11-13 |
| 2023-06-30 | 78.00K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | 303.00K shares 10-Q · filed 2023-08-14 | 473.00K shares derived: sum of 3 quarters · filed 2023-08-14 | 490.00K shares derived: sum of 4 quarters · filed 2023-08-14 |
| 2023-03-31 | 225.00K shares 10-Q · filed 2023-05-10 | 395.00K shares derived: sum of 2 quarters · filed 2023-05-10 | 412.00K shares derived: sum of 3 quarters · filed 2023-05-10 | 508.50K shares derived: sum of 4 quarters · filed 2023-05-10 |
| 2022-12-31 | 170.00K shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | 187.00K shares derived: sum of 2 quarters · filed 2023-03-31 | 283.50K shares derived: sum of 3 quarters · filed 2023-03-31 | 834.00K shares 10-K · filed 2023-03-31 |
| 2022-09-30 | 17.00K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | 113.50K shares derived: sum of 2 quarters · filed 2022-11-09 | 664.00K shares 10-Q · filed 2022-11-09 | 699.30K shares derived: sum of 4 quarters · filed 2022-11-09 |
| 2022-06-30 | 96.50K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-15 | 647.00K shares 10-Q · filed 2022-08-15 | 682.30K shares derived: sum of 3 quarters · filed 2022-08-15 | 724.00K shares derived: sum of 4 quarters · filed 2022-08-15 |
| 2022-03-31 | 550.50K shares 10-Q · filed 2022-05-12 | 585.80K shares derived: sum of 2 quarters · filed 2022-05-12 | 627.50K shares derived: sum of 3 quarters · filed 2022-05-12 | 879.10K shares derived: sum of 4 quarters · filed 2022-05-12 |
| 2021-12-31 | 35.30K shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-29 | 77.00K shares derived: sum of 2 quarters · filed 2022-03-29 | 328.60K shares derived: sum of 3 quarters · filed 2022-03-29 | 874.05K shares 10-K · filed 2022-03-29 |
| 2021-09-30 | 41.70K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | 293.30K shares derived: sum of 2 quarters · filed 2021-11-10 | 838.75K shares 10-Q · filed 2021-11-10 | 863.75K shares derived: sum of 4 quarters · filed 2021-11-10 |
| 2021-06-30 | 251.60K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-16 | 797.05K shares 10-Q · filed 2021-08-16 | 822.05K shares derived: sum of 3 quarters · filed 2021-08-16 | 867.95K shares derived: sum of 4 quarters · filed 2021-08-16 |
| 2021-03-31 | 545.45K shares 10-Q · filed 2021-05-17 | 570.45K shares derived: sum of 2 quarters · filed 2021-05-17 | 616.35K shares derived: sum of 3 quarters · filed 2021-05-17 | -1.67M shares derived: sum of 4 quarters · filed 2021-05-17 |
| 2020-12-31 | 25.00K shares derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-29 | 70.90K shares derived: sum of 2 quarters · filed 2021-03-29 | -2.21M shares derived: sum of 3 quarters · filed 2021-03-29 | 349.44K shares 10-K · filed 2021-03-29 |
| 2020-09-30 | 45.90K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-06 | -2.24M shares derived: sum of 2 quarters · filed 2020-11-06 | 324.44K shares 10-Q · filed 2020-11-06 | 396.44K shares derived: sum of 4 quarters · filed 2020-11-06 |
| 2020-06-30 | -2.28M shares derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-10 | 278.54K shares 10-Q · filed 2020-08-10 | 350.54K shares derived: sum of 3 quarters · filed 2020-08-10 | 365.54K shares derived: sum of 4 quarters · filed 2020-08-10 |
| 2020-03-31 | 2.56M shares 10-Q · filed 2020-05-11 | 2.64M shares derived: sum of 2 quarters · filed 2020-05-11 | 2.65M shares derived: sum of 3 quarters · filed 2020-05-11 | 2.99M shares derived: sum of 4 quarters · filed 2020-05-11 |
| 2019-12-31 | 72.00K shares derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-11 | 87.00K shares derived: sum of 2 quarters · filed 2020-03-11 | 431.00K shares derived: sum of 3 quarters · filed 2020-03-11 | 1.70M shares 10-K · filed 2020-03-11 |
| 2019-09-30 | 15.00K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12 | 359.00K shares derived: sum of 2 quarters · filed 2019-11-12 | 1.63M shares 10-Q · filed 2019-11-12 | 1.67M shares derived: sum of 4 quarters · filed 2019-11-12 |
| 2019-06-30 | 344.00K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-07 | 1.61M shares 10-Q · filed 2019-08-07 | 1.66M shares derived: sum of 3 quarters · filed 2019-08-07 | 1.73M shares derived: sum of 4 quarters · filed 2019-08-07 |
| 2019-03-31 | 1.27M shares 10-Q · filed 2019-05-08 | 1.31M shares derived: sum of 2 quarters · filed 2019-05-08 | 1.38M shares derived: sum of 3 quarters · filed 2019-05-08 | 1.42M shares derived: sum of 4 quarters · filed 2019-05-08 |
| 2018-12-31 | 41.59K shares derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-14 | 111.40K shares derived: sum of 2 quarters · filed 2019-03-14 | 148.06K shares derived: sum of 3 quarters · filed 2019-03-14 | 1.26M shares 10-K · filed 2019-03-14 |
| 2018-09-30 | 69.81K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-13 | 106.47K shares derived: sum of 2 quarters · filed 2018-11-13 | 1.22M shares 10-Q · filed 2018-11-13 | 1.41M shares derived: sum of 4 quarters · filed 2019-03-14 |
| 2018-06-30 | 36.66K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-09 | 1.15M shares 10-Q · filed 2018-08-09 | 1.34M shares derived: sum of 3 quarters · filed 2019-03-14 | 1.42M shares derived: sum of 4 quarters · filed 2019-03-14 |
| 2018-03-31 | 1.11M shares 10-Q · filed 2018-05-08 | 1.30M shares derived: sum of 2 quarters · filed 2019-03-14 | 1.39M shares derived: sum of 3 quarters · filed 2019-03-14 | 1.42M shares derived: sum of 4 quarters · filed 2019-03-14 |
| 2017-12-31 | 187.85K shares derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-14 | 273.97K shares derived: sum of 2 quarters · filed 2019-03-14 | 306.11K shares derived: sum of 3 quarters · filed 2019-03-14 | 1.26M shares 10-K · filed 2019-03-14 |
| 2017-09-30 | 86.12K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-07 | 118.26K shares derived: sum of 2 quarters · filed 2017-11-07 | 1.07M shares 10-Q · filed 2017-11-07 | |
| 2017-06-30 | 32.15K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-08 | 982.80K shares 10-Q · filed 2017-08-08 | ||
| 2017-03-31 | 950.66K shares 10-Q · filed 2017-05-08 | |||
| 2016-12-31 | 497.98K shares 10-K · filed 2018-03-13 | |||
| 2015-12-31 | 880.12K shares 10-K · filed 2017-03-13 | |||
| 2014-12-31 | 520.89K shares 10-K · filed 2016-03-07 | |||
| 2013-12-31 | 11.53K shares 8-K · filed 2015-10-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PDS Biotechnology Corp (PDSB) | United States | $0.045B | |
| Grace Therapeutics, Inc. (GRCE) | $0.046B | -1.83 | |
| VERU INC. (VERU) | United States | $0.043B | -3.93 |
| Werewolf Therapeutics, Inc. (HOWL) | United States | $0.047B | |
| Kairos Pharma, LTD. (KAPA) | United States | $0.041B | |
| Dogwood Therapeutics, Inc. (DWTX) | United States | $0.049B | |
| Lite Strategy, Inc. (LITS) | United States | $0.049B | |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| Elicio Therapeutics, Inc. (ELTX) | United States | $0.049B | |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |